About Maya Clinicals Drug Development Private Limited
Data last updated:
Maya Clinicals Drug Development Private Limited was a private limited company based in Hyderabad, Telangana, India. The company has been struck off by the Registrar of Companies, typically due to non-filing of annual returns or failure to commence business. It is no longer operational and cannot enter into any legal contracts or agreements. It operated in the research and development sector. It was incorporated on 27 July 2009.
The company was registered with the Registrar of Companies (ROC), Hyderabad, under CIN U73100TG2009PTC064502. The company has 1 GST registration on record, which is no longer active.
The company had an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It was led by directors Jhansirani Yerramreddy Reddy and Baby Kodali Reddy Jakka.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office was at Hyderabad, Telangana.
As per the financials filed for FY 2017, the company reported a revenue of ₹1.66 Cr. For the same year it recorded a net profit of ₹1.46 Lakh (net margin 0.9%) and EBITDA of ₹3.94 Lakh (EBITDA margin 2.4%).
The company was associated with 1 brand: Maya Clinicals.
The last known website on record is mayaclinicals.com.
Company details
CIN history
Maya Clinicals Drug Development has one previous CIN (Corporate Identification Number): U73100AP2009PTC064502. The current CIN is U73100TG2009PTC064502, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U73100TG2009PTC064502 | Current |
| U73100AP2009PTC064502 | Previous |
Contact details
Maya Clinicals Drug Development Private Limited's registered office is in Hyderabad, Telangana. Its website is mayaclinicals.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressFlat No. 604 7th Floor Cyber Heights Behind Tdp Office Road No – 2 Banjara, Hills, Hyderabad, Telangana, India – 500034
- IndustryResearch & Development, Research & Development
To see the full contact details of Maya Clinicals Drug Development Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Maya Clinicals Drug Development operates one associated brand: Maya Clinicals. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Serves as a global CRO with a network of sites, MDs, and specialists in India. | mayaclinicals.com |
Financials of Maya Clinicals Drug Development Private Limited
FY 2024 filings availableMaya Clinicals Drug Development Private Limited reported revenue of ₹1.66 Cr for FY 2017.
Financial Statement Summary
| Metrics | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | ₹1.66 Cr | ||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | ₹3.94 Lakh | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | ₹1.46 Lakh | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | 2.4% | ||
| Net Profit Margin | 0.9% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Maya Clinicals Drug Development Private Limited, buy the company report.
Board of directors of Maya Clinicals Drug Development Private Limited
Maya Clinicals Drug Development has 2 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Jhansirani Yerramreddy Reddy | Director | 12 Sep 2009 | 17 Years 1 Months | As last reported |
| Baby Kodali Reddy Jakka | Director | 02 May 2016 | 10 Years 6 Months | As last reported |
Auditor
Maya Clinicals Drug Development Private Limited is audited by Phaneendra & Co for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Phaneendra & Co | FY 2017 | 012446S |
Shareholding
The shareholding of Maya Clinicals Drug Development Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Maya Clinicals Drug Development Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Maya Clinicals Drug Development Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Maya Clinicals Drug Development Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Maya Clinicals Drug Development has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Maya Clinicals Drug Development Private Limited, buy the company report.
Recent activity
Maya Clinicals Drug Development Private Limited has 10 board changes on record since 2009: 6 appointments and 4 cessations. The latest: Radha Reddy Jakka ceased to be Director on 25 May 2020.
1 earlier event is in the company report.
Frequently asked questions
Maya Clinicals Drug Development has a status of "Struck Off" as per MCA records. This means the company has been officially removed from the Register of Companies, typically due to non-filing of annual returns or failure to commence business within one year of incorporation. A struck-off company cannot enter into any legal contracts or agreements, and any dealings with such an entity carry significant legal and financial risk.
Maya Clinicals Drug Development was a private limited company based in Hyderabad, Telangana, India. The company worked in the research and development industry. It was incorporated on 27 July 2009 and is registered under CIN U73100TG2009PTC064502. The company has been struck off by the Registrar of Companies and is no longer operational.
Maya Clinicals Drug Development had 2 directors:
- Jhansirani Yerramreddy Reddy - Director
- Baby Kodali Reddy Jakka - Director
The CIN (Corporate Identification Number) of Maya Clinicals Drug Development is U73100TG2009PTC064502. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Maya Clinicals Drug Development is at Flat No. 604 7th Floor Cyber Heights Behind Tdp Office Road No – 2 Banjara, Hills, Hyderabad, Telangana, India – 500034.
Maya Clinicals Drug Development was incorporated on 27 July 2009. It is registered with the Registrar of Companies, Hyderabad.
Maya Clinicals Drug Development can be reached through the website mayaclinicals.com. Its registered office is in Hyderabad, Telangana, India.
The latest financial statements of Maya Clinicals Drug Development on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
No. Maya Clinicals Drug Development has 1 GST registration on record and it is cancelled or inactive.
Maya Clinicals Drug Development operated in the research and development industry. It worked in this industry before it was struck off.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
